Search bioRxiv⌕ Search

Biology subjects

Cabral, V.

Publications and source records attributed to Cabral, V..

3 recordsLinked to original sources

Biofilms promote tolerance and stability in gut bacterial communities during bile acid stress

Several mechanisms have been described to explain how bacterial species colonize and persist in the mammalian gut. However, biofilm formation remains underexplored as a mechanism for gut microbiota symbiont persistence. While evidence of biofilm formation by individual gut symbionts is beginning to emerge, its occurrence and relevance in multispecies gut microbiota communities remain poorly studied. Here, we established an in vitro model to study multispecies gut microbiota biofilms using the Oligo-Mouse Microbiota 12 (OMM12) consortium, a defined community of murine gut isolates. We investigated community biofilm formation and responses to bile acids, host-derived detergent-like molecules released into the gut that can perturb bacterial growth and community structure. We identified distinct contributions of two OMM12 members: removal of Enterococcus faecalis strongly reduced community biofilm biomass, whereas removal of Bacteroides caecimuris had limited effect on biomass but strongly altered species associations. These results, together with monoculture assays, show that individual biofilm capacity does not directly predict community-level contribution. Moreover, planktonic and biofilm communities had markedly distinct responses to bile acid stress. Planktonic cultures, while more susceptible to bile acids, showed resilience by recovering growth yield within 24 hours upon bile stress removal. Community biofilms, in contrast, showed greater tolerance to bile acid stress and more species associations. Overall, our findings support biofilms as a community-level lifestyle that can buffer defined gut microbiota communities against host-associated chemical perturbations.

microbiology↗

Novel gut probiotic engages microbiota for recovery and pathobiont clearance while preventing inflammation

The microbiota inhabiting the mammalian gut serves as a protective barrier against pathogen invasion through a mechanism known as colonization resistance. Antibiotic treatments can inadvertently disturb the gut microbiota, compromising colonization resistance and increasing hosts susceptible to infections. Non-pneumoniae Klebsiella spp. members of the gut microbiota play a crucial role in colonization resistance and clearance from the gut of pathogenic Enterobacteriaceae following antibiotic-induced perturbations. Specifically, Klebsiella strain ARO112 a gut microbiota isolate, can effectively resist and clear Escherichia coli colonization after antibiotic-induced dysbiosis. We assessed the potential of Klebsiella sp ARO112 to promote clearance of Enterobacteriaceae pathobiont Adherent-Invasive E. coli (AIEC) in an Inflammatory Bowel Disease (IBD) mouse model susceptible to inflammatory episodes. In antibiotic-treated IBD-predisposed mice infected with the AIEC, Klebsiella sp. ARO112 promoted a faster recovery of gut microbiota members potentially involved in butyrate production and accelerated pathobiont clearance. Functionally, ARO112-driven microbiota recovery promoted higher butyrate levels and prevented intestinal inflammation compared to untreated animals. Conversely, treatment with the well-known probiotic E. coli Nissle 1917 enhanced AIEC colonization and inflammation. Furthermore, we assessed the safety of ARO112 as a potential next-generation probiotic; phenotypic comparison of ARO112 against closely related Enterobacteriaceae revealed its lower pathogenic potential, including being more recalcitrant to antibiotic resistance acquisition. Overall, our results showing that Klebsiella sp. ARO112 can resolve infections while contributing to the promotion of intestinal health, underscore its potential as a biotherapy agent that can disrupt inflammation-treatment-infection cycles. This potential extends beyond IBD patients, encompassing individuals with other inflammatory-based conditions related to microbiota imbalances.

microbiology↗

Generating genomic platforms to study Candida albicans pathogenesis

The advent of the genomic era has made elucidating gene function at large scale a pressing challenge. ORFeome collections, whereby almost all ORFs of a given species are cloned and can be subsequently leveraged in multiple functional genomic approaches, represent valuable resources towards this endeavor. Here we provide novel, genome-scale tools for the study of Candida albicans, a commensal yeast that is also responsible for frequent superficial and disseminated infections in humans. We have generated an ORFeome collection composed of 5,102 ORFs cloned in a Gateway donor vector, representing 83% of the currently annotated coding sequences of C. albicans. Sequencing data of the cloned ORFs are available in the CandidaOrfDB database at http://candidaorfeome.eu. We also engineered 49 expression vectors with a choice of promoters, tags, and selection markers and demonstrated their applicability to the study of target ORFs transferred from the C. albicans ORFeome. In addition, the use of the ORFeome in the detection of protein-protein interaction was demonstrated. Mating-compatible strains as well as Gateway-compatible two-hybrid vectors were engineered, validated and used in a proof of concept experiment. These unique and valuable resources should greatly facilitate future functional studies in C. albicans and the elucidation of mechanisms that underlie its pathogenicity.

genomics↗